Kerala Ayurveda Ltd (KAL), one of India’s oldest full-spectrum, publicly listed Ayurveda companies, has reaffirmed its commitment to its Vision 2030 strategy, which targets scaling consolidated revenues to ₹1,000 crore by the end of the decade. The growth roadmap is anchored around high-potential segments such as the global e-products business and the health services vertical, supported by investments in talent, technology, and international expansion.
The Vision 2030 plan is designed to strengthen KAL’s positioning as a global Ayurveda leader while driving sustainable, multi-segment growth. To support this next phase of expansion, the company has indicated its intent to raise fresh investments, reinforcing its capital base for long-term scale.
Kerala Ayurveda operates an integrated ecosystem spanning academies, wellness resorts, hospitals, clinics, products, and services across India and the United States. The company offers a portfolio of over 400 products and serves nearly 100,000 patients annually.
Its international education arm, Kerala Ayurveda Academy, USA—based in California—has trained and certified more than 3,500 graduates, underscoring the company’s focus on knowledge-led global expansion of Ayurveda.
In a significant governance and balance-sheet strengthening move, KAL recently announced a proposal by its promoter group to convert ₹20 crore of promoter debt into equity through a preferential allotment. The shares are proposed to be issued at ₹327.99 per share, representing a 31.9% premium to the closing price on February 11, subject to shareholder approval.
Approval for the conversion will be sought at an Extraordinary General Meeting scheduled for March 14. The move is being viewed as a strong signal of the promoters’ long-term commitment and confidence in the company’s Vision 2030 roadmap, while also improving the company’s leverage profile.
KAL also announced its intent to acquire the remaining external shareholding in its subsidiary Ayurvedagram Heritage Wellness Centre Pvt Ltd (AHWCPL), which operates the internationally recognised Ayurvedagram wellness retreat in Bangalore.
AHWCPL reported a turnover of ₹13.5 crore in FY25. Kerala Ayurveda proposes to acquire the balance 26% equity stake for ₹10 crore through a preferential issue of KAL shares. Upon completion, AHWCPL will become a wholly owned subsidiary, with plans for a future merger into the parent entity. The consolidation is expected to unlock operational synergies and potential tax benefits over the medium term.
Management stated that the company is on track to deliver ₹150 crore in consolidated revenue in FY26, representing a 23% year-on-year growth. This performance would extend the strong growth trajectory seen since the launch of the company’s KAL 2.0 transformation journey, which focuses on scalability, profitability, and global brand building.
With promoter backing, balance-sheet strengthening initiatives, and a clearly articulated long-term vision, Kerala Ayurveda is positioning itself for its next phase of growth—blending traditional Ayurvedic wisdom with modern, globally scalable business models.